http://www.mercury-freedrugs.org/docs/07930_PR_UrineTestingConfirmsAutismIsMercuryPoisoningb.pdf

Urine Testing Confirms Autism is Mercury Poisoning
Press Release Contact:
For Immediate Release CoMeD President [Rev. Lisa K. Sykes (Richmond, VA)
804-364-8426]
September 30, 2007 CoMeD Sci. Advisor [Dr. King (Lake Hiawatha, NJ)
973-997-1321]

WASHINGTON, DC - A new peer-reviewed scientific/medical case study confirms
that many children with autistic spectrum disorders (ASDs) suffer from
mercury poisoning. The new study, "A Prospective Study of Mercury Toxicity
Biomarkers in Autistic Spectrum Disorders" by Mr. David A. Geier and Dr.
Mark R. Geier has been published in the most recent issue of the Journal of
Toxicology and Environmental Health, Part A (volume 70, issue 20, pgs
1723-1730).

This study utilized urinary porphyrin profile analysis (UPPA) to assess
body-burden and physiological effects of mercury in children diagnosed with
ASDs.
Using UPPA, Geier and Geier (2007) examined 71 children diagnosed with
ASDs, 9 neurotypical siblings, and 5 general population controls. The
researchers studied urinary porphyrin patterns using results reported both
by the US Laboratory Corporation of America (LabCorp) and the French
Laboratoire Philippe Auguste.

Their findings demonstrated that:
. Only the non-chelated patients diagnosed with ASDs had porphyrin patterns
indicative of clinical mercury toxicity.
. Treating ASD diagnosed patients with chelating agents resulted in lower
mercury-specific urinary porphyrins.
. The UPPA patterns reported were consistent between the two labs used.

The results of the present study confirm and extend previous observations
by Nataf et al. (2006) and Geier and Geier (2006) on the use of UPPA
profiling to establish the causal role for mercury in ASDs. Additionally,
the current findings are consistent with those observed by many other
physicians who treat patients diagnosed with both ASDs and mercury toxicity.

Thus, urinary porphyrin profile testing is being successfully used to:
. Demonstrate the role of mercury in ASD populations,
. Identify those children and adults who are mercury poisoned, and
. Track mercury excretion from affected children undergoing treatment.

For the past several years there has been a raging controversy as to
whether or not mercury in medicines, especially in vaccines, has caused a
dramatic rise in the rate of children diagnosed with an ASD. Many experts
have insisted ASDs are caused by some yet-to-be-identified genetic cause. A
paper recently published in Nature Genetics described the results of
multi-million-dollar genetics study (which studied a thousand-plus families
with at least two children diagnosed with an ASD using in-depth genetic
screening). Tellingly, the authors reported, "None of our linkage results
can be interpreted as 'statistically significant'."(The Autism Genome
Project Consortium 2007).

With the current study's results, public health officials should now
publicly admit what they have been saying in their private transcripts and
memos: Mercury from Thimerosal-containing vaccines and other medicines has
been a major cause of ASD cases, which, based on recent CDC estimates (CDC
2007), may, when corrected for under ascertainment, exceed a rate of one in
100 children.

Today, any parent, physician, or healthcare provider can easily confirm
whether a non-chelated child with an ASD diagnosis is mercury poisoned by
having UPPA testing run at either laboratory.

CoMeD's web site, http://www.Mercury-freeDrugs.org contains:
. Further information on how to order these tests,
. Full copies of the Nataf et al. (2006), Geier and Geier (2006), & Geier
and Geier (2007), and
. Some of the many published papers validating the UPPA test.